Sky Century Investment (SKYI) Shares Outstanding (2012 - 2026)
Sky Century Investment (SKYI) posted quarterly Shares Outstanding (Entity) of $3.9 million for Q2 2026, down 98.24% year-over-year from $223.5 million in Q2 2025, and up 76.05% quarter-over-quarter from $2.2 million in Q1 2026.
Sky Century Investment (SKYI) Shares Outstanding (2012 - 2026) Analysis & Trends
Sky Century Investment (SKYI) has reported Shares Outstanding (Entity) for 6 consecutive years, with $3.9 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Shares Outstanding (Entity) fell 98.24% year-over-year to $3.9 million; the TTM figure through May 2026 stood at $3.9 million (down 98.24% YoY), while the FY2025 annual figure was $223.5 million, up 1.32% from the prior year.
- Shares Outstanding (Entity) climbed to $3.9 million in Q2 2026 per SKYI's latest filing, from $2.2 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $223.5 million in Q1 2025 and bottomed at $2.2 million in Q1 2026.
- Historically, Shares Outstanding (Entity) has averaged $178.3 million across 3 years, with a median of $220.6 million in 2024.
- Annual changes were most pronounced in 2025 — Shares Outstanding (Entity) advanced 1.32% — and 2026, when it sank 99.0%.
- Sky Century Investment's Shares Outstanding (Entity) stood at $220.6 million in 2024, then grew by 1.32% to $223.5 million in 2025, then slumped by 98.24% to $3.9 million in 2026.
- Business Quant data shows SKYI's Shares Outstanding (Entity) at $3.9 million in Q2 2026, $2.2 million in Q1 2026, and $223.5 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 832.44 Mn |
| 10 | Sky Century Investment | 393,547.71 | 393,283.71 | 26,045.00 | 3.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 3.94 Mn |
| Feb 28, 2026 | 2.24 Mn |
| Nov 30, 2025 | 223.55 Mn |
| Aug 31, 2025 | 222.65 Mn |
| May 31, 2025 | 223.55 Mn |
| Feb 28, 2025 | 222.84 Mn |
| Nov 30, 2024 | 220.64 Mn |
| Aug 31, 2024 | 220.64 Mn |
| May 31, 2024 | 220.64 Mn |
| Feb 29, 2024 | 220.64 Mn |
| Aug 31, 2014 | 110.02 Mn |
| May 31, 2014 | 101.80 Mn |
| Feb 28, 2014 | 983.22 Mn |
| Nov 30, 2013 | 6.27 Mn |
| Aug 31, 2013 | 6.09 Mn |
| May 31, 2013 | 6.00 Mn |
| Feb 28, 2013 | 1.12 Bn |
| Nov 30, 2012 | 6.00 Mn |
| Aug 31, 2012 | 6.00 Mn |